|
|
||||||||
J Thorac Cardiovasc Surg 2008;135:98-105
© 2008 The American Association for Thoracic Surgery
Surgery for Congenital Heart Disease |


a Division of Pediatric Cardiology, Department of Pediatrics, Schneider Childrens Hospital, New Hyde Park, New York
b Department of Cardiothoracic Surgery, Schneider Childrens Hospital, New Hyde Park, New York
c Biostatistics Unit, The Feinstein Institute for Medical Research, Manhasset, New York
d Center for Oncology/Cell Biology, The Feinstein Institute for Medical Research, Manhasset, New York.
Received for publication April 20, 2007; revisions received August 6, 2007; accepted for publication August 15, 2007. * Address for reprints: Kaie Ojamaa, PhD, The Feinstein Institute for Medical Research, 350 Community Dr, Manhasset, NY 11030. (Email: kojamaa{at}nshs.edu).
Objectives: The objectives of this study were to measure circulating N-terminal B-type natriuretic peptide levels in pediatric patients undergoing surgical repair of congenital heart lesions with left ventricular volume overload and to determine whether presurgical and immediate postoperative N-terminal B-type natriuretic peptide levels could predict patient outcomes after surgical intervention.
Methods: Thirty-eight children aged 1 to 36 months undergoing surgical repair of cardiac lesions with left ventricular volume overload were studied. Plasma N-terminal B-type natriuretic peptide levels were measured preoperatively and at 2, 12, 24, 48, and 72 hours after surgical intervention and were assessed for their predictive value of postoperative outcomes. Plasma N-terminal B-type natriuretic peptide levels were also measured in 34 similarly aged healthy children.
Results: Patient preoperative N-terminal B-type natriuretic peptide levels were significantly higher than those of healthy control subjects (3085 ± 4046 vs 105 ± 78 pg/mL). Preoperative N-terminal B-type natriuretic peptide levels correlated with the complexity of surgical repair, as measured by cardiopulmonary bypass time (r = 0.529, P < .001), and with postoperative measures, including fractional inhaled oxygen requirements registered at 12 hours (r = 0.443, P = .005) and duration of mechanical ventilation (r = 0.445, P = .005). Plasma N-terminal B-type natriuretic peptide levels increased 5-fold within 12 hours after cardiopulmonary bypass (14,685 ± 14,317 pg/mL). Multivariable regression analysis showed that the preoperative N-terminal B-type natriuretic peptide level was a significant predictor of duration of intensive care unit stay (P = .02) and that the peak postoperative N-terminal B-type natriuretic peptide level was a significant predictor of the intensity of overall medical management, as assessed by using the therapeutic intervention scoring system (P = .01).
Conclusion: Plasma N-terminal B-type natriuretic peptide levels measured preoperatively and postoperatively can be a prognostic indicator in the management of the pediatric patient after surgical intervention for congenital heart repair.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |